Horner

Horner, officially Frank W. Horner Ltd., is a historic Canadian pharmaceutical company that played a foundational role in the country's life sciences sector. Founded in 1912 and headquartered in Montreal, the company specialized in the development and commercialization of a broad range of therapeutic products. In 1990, Horner was acquired by the French international pharmaceutical company Servier, leading to the creation of Servier Canada. Today, the Horner legacy is integrated into Servier's operations, focusing on therapeutic areas such as cardiovascular disease, metabolic disorders, and oncology. The company remains a key entity for clinical trials and the distribution of innovative medicines across the Canadian market.